Budenofalk治疗哮喘效果怎样？

布地奈德()肠溶缓释胶囊是一线抗炎药和局部作用的糖皮质激素，用于诱导和维持轻度至中度回盲肠克罗恩病（胶囊）和溃疡性结肠炎（灌肠）的缓解以及活性物质的缓解。 and patients with glucocorticoid-dependent or -independent bronchial asthma and asthmatic chronic bronchitis. How effective is Budenofalk in treating asthma?

The trial explores the impact of two inhaled therapies on the efficacy and care of severe asthma. Forty patients with severe asthma were randomly divided into two groups, with 20 cases in each group. The experimental group used the mist storage inhalation method, and the control group inhaled according to the aerosol instructions. The values ​​of forced expiratory volume in the first second (FEV1) and peak expiratory flow rate (PEF) were measured before and after treatment. The difference in FEV1 and PEF values ​​between the two groups after treatment was statistically significant (P<0.01); the comparison of the efficacy between the two groups was statistically significant (P<0.01). The effect of using spacer inhalation method to treat Budenofalk's asthma is more significant.

How to use: The dosage for atomization is generally 1-2 mg once for adults, twice a day; for children, 0.5-1 mg once, twice a day. The maintenance dose should be individualized, that is, the lowest dose to maintain no symptoms. It is recommended that adults take 0.5-1 mg twice a day and children 0.25-0.5 mg twice a day. Swallow the capsule of Budenofalk completely with enough liquid (e.g. a glass of water) about 30 minutes before a meal. The recommended daily dose of Budenofalk is 1 tablet containing 3 mg of budesonide, 3 times daily (morning, noon and evening). The effectiveness of Budenofalk does not decrease. The course of treatment usually lasts 8 weeks. Generally, full effects occur in 2-4 weeks. Do not stop taking Budenofalk suddenly, you need to gradually reduce your dose.